Ireland: Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5m (US$25m) Series A investment round led by new investors LSP (from its Health Economics Fund 2) and Seroba Life Sciences, joined by new investor SV Health (from its Medtech Convergence Fund) and…
©2023 All rights reserved LaingBuisson 
